Search
Chlorproguanil
go.drugbank.com/drugs/DB12314InvestigationalIt is a dichloro-derivative of chloroguanide.
Ethyl butyrate
go.drugbank.com/drugs/DB15454ExperimentalEthyl butyrate is under investigation in clinical trial NCT03202342 (fMRI of Hypothalamic Responses to Taste, Temperature and Glucose).
Venglustat
go.drugbank.com/drugs/DB14966InvestigationalVenglustat is under investigation in clinical trial NCT01674036 (Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men).
Ultevursen
go.drugbank.com/drugs/DB17835InvestigationalIt was developed by ProQR Therapeutics and is being investigated for the treatment of retinitis pigmentosa. … Ultevursen is a single-stranded RNA-based oligonucleotide targeting exon 13 of the USH2A gene that encodes usherin.
Ulixertinib
go.drugbank.com/drugs/DB13930InvestigationalIt is currently in clinical trials for the treatment of a wide range of tumors. … Ulixertinib is a a novel, reversible, ATP-competitive ERK1/2 inhibitor with high potency and ERK1/2 selectivity [A31474].
Thiostrepton
go.drugbank.com/drugs/DB11467InvestigationalVet approvedThiostrepton is a natural product of the ribosomally synthesized and post-translationally modified peptide class. … Thiostrepton is a natural cyclic oligopeptide antibiotic, derived from several strains of streptomycetes including Streptomyces azureus and Streptomyces laurentii.
Nizaracianine
go.drugbank.com/drugs/DB21517InvestigationalNizaracianine is a small molecule drug. Nizaracianine is under investigation in clinical trial NCT05752149 (Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial).
Carbenoxolone
go.drugbank.com/drugs/DB02329ExperimentalIt is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity. [PubChem]
(S)-AMPA
go.drugbank.com/drugs/DB02057ExperimentalAMPA is a specific agonist for the AMPA receptor.
Synonyms: S-AMPA, (S)-AMPAIK-930
go.drugbank.com/drugs/DB18149InvestigationalIK-930 is an oral, paralog-selective TEAD inhibitor.